In celebration of its 100th year as an institution open to the public, the Morgan Library and Museum has launched the ...

On Friday, bluebird bio Inc (BLUE) stock saw a decline, ending the day at $0.48 which represents a decrease of $-0.02 or -4.00% from the prior close of $0.5. The stock opened at $0.5 and touched a low ...

J.P. Morgan analyst Eric Joseph maintained a Buy rating on Rocket Pharmaceuticals (RCKT – Research Report) yesterday and set a price ...

JP Morgan has recently reduced bluebird bio Inc (BLUE) stock to Neutral rating, as announced on August 15, 2024, according to Finviz. Earlier, on December 11, 2023, HSBC Securities had reduced the ...

(Reuters) -Shares in European vaccine makers fell on Friday after U.S. President-elect Donald Trump picked Robert F. Kennedy ...

Tessa Romero, an analyst from J.P. Morgan, has initiated a new Buy rating on Upstream Bio, Inc. (UPB). Tessa Romero’s rating is based on ...

A New York exhibition pays homage to a Black woman who passed as white and assembled the financier’s private collection ...

Until the publication of her biography and The New Yorker excerpt ... s ethnicity occasionally surfaced at the library, where J.P. Morgan’s son, Jack, succeeded his father in 1913.

Belite Bio, Inc. ( NASDAQ: BLTE) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Tom Lin - Chairman and Chief Executive Officer Hendrik Scholl - Chief Medical Officer Nathan Mata - Chief ...

Rosy Wellness and Kindly Human won top honors at Venture Dallas 2024, showcasing innovative solutions in women’s health and ...

JPMorgan analyst Jessica Fye lowered the firm’s price target on BioMarin (BMRN) to $109 from $110 and keeps an Overweight rating on the shares post the Q3 report. The firm sees an attractive ...